|
|
|
| The prognostic role of inflammatory markers in patiens with nasopharyngeal carcinoma#br# |
| LI Qian HU Qinyong |
| Cancer Center, Renmin Hospital of Wuhan University, Hubei Province, Wuhan 430060, China |
|
|
|
Abstract Inflammation plays an important role in the occurrence and development of various cancers. Inflammatory markers have the characteristics of low cost, stable results and convenience, which have been widely used in lung cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer and other malignant tumors to predict the prognosis of patients. Inflammation markers have been a hot spot in cancer research in recent years. However, there are relatively few studies on inflammatory markers in nasopharyngeal carcinoma and the conclusions are different. Therefore, this article reviews the widely studied inflammatory markers, such as neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and lymphocyte-to-monocyte ratio, as well as the recent development of emerging inflammatory markers such as systemic immune inflammation index, systemic inflammation response index, prognostic nutritional index, Glasgow prognostic score and C-reactive protein/albumin ratio in nasopharyngeal carcinoma. It aims to supplement the traditional prognostic factors of nasopharyngeal carcinoma and help to provide better personalized treatment plans for cancer patients.
|
|
|
|
|
|
[1] Lee AWM，Ng WT，Chan JYW，et al. Management of locally recurrent nasopharyngeal. carcinoma [J]. Cancer Treat Rev，2019，79：101890.
[2] Schmidt A，Weber OF. In memoriam of Rudolf virchow：a historical retrospective including aspects of inflammation，infection and neoplasia[J]. Contrib Microbiol，2006，13：1-15.
[3] Mantovani A，Allavena P，Sica A，et al. Cancer-related inflammation [J]. Nature，2008，454（7203）：436-444.
[4] Khandia R，Munjal A. Interplay between inflammation and cancer [J]. Adv Protein Chem Struct Biol，2020，119：199-245.
[5] Kusumanto YH，Dam WA，Hospers GA，et al. Platelets and granulocytes，in particular the neutrophils，form important compartments for circulating vascular endothelial growth factor [J]. Angiogenesis，2003，6（4）：283-287.
[6] An X，Ding PR，Wang FH，et al. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma [J]. Tumour Biol，2011，32（2）：317-324.
[7] Jin Y，Ye X，He C，et al. Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma [J]. Head Neck，2015， 37（1）：69-75.
[8] Chua ML，Tan SH，Kusumawidjaja G，et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma： A pooled analysis of two randomised controlled trials [J]. Eur J Cancer，2016， 67：119-129.
[9] Pan XB，Huang ST，Zhu XD. Neutrophil-to-lymphocyte ratio predicts the prognosis of stage II nasopharyngeal carcinoma [J]. Cancer Manag Res，2019，11：8269-8275.
[10] Yao JJ，Zhu FT，Dong J，et al. Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma： a large institution-based cohort study from an endemic area [J]. BMC Cancer，2019，19（1）：37.
[11] Zhao L，Chen H，Hu B，et al. Prognostic significance of Ki67 expression and the derived neutrophil-lymphocyte ratio in nasopharyngeal carcinoma [J]. Cancer Manag Res，2018，10：1919-1926.
[12] Huang L，Liu S，Lei Y，et al. Systemic immune-inflammation index，thymidine phosphorylase and survival of localized gastric cancer patients after curative resection [J]. Oncotarget，2016，7（28）：44185-44193.
[13] Labelle M，Begum S，Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis [J]. Cancer Cell，2011，20（5）：576-590.
[14] Jiang R，Zou X，Hu W，et al. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients [J]. Tumour Biol，2015， 36（10）：7775-7787.
[15] Jiang Y，Qu S，Pan X，et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma [J]. Oncotarget，2018，9（11）：9992-10004.
[16] Hefler L，Tempfer C，Heinze G，et al. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients [J]. Br J Cancer，1999，81（5）：855-859.
[17] Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis [J]. Nat Rev Cancer，2004，4（1）：71-78.
[18] Liu JF，Chen PC，Chang TM，et al. Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma [J]. J Exp Clin Cancer Res，2020，39（1）：254.
[19] Zhou JW，Mao YH，Liu Y，et al. A novel robust nomogram based on peripheral monocyte counts for predicting lymph node metastasis of prostate cancer [J]. Asian J Androl，2021，23（4）：409-414.
[20] Burgess B，Levine B，Taylor RN，et al. Preoperative Circulating Lymphocyte and Monocyte Counts Correlate with Patient Outcomes in Type Ⅰ and Type Ⅱ Endometrial Cancer [J]. Reprod Sci，2020，27（1）：194-203.
[21] Li J，Jiang R，Liu WS，et al. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma [J]. PLoS One，2013，8（12）：e83069.
[22] Li ZM，Huang JJ，Xia Y，et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP [J]. PLoS One，2012，7（7）：e41658.
[23] Porrata LF，Ristow K，Colgan JP，et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma [J]. Haematologica，2012， 97（2）：262-269.
[24] Lin GN，Peng JW，Liu DY，et al. Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy [J]. Tumour Biol，2014， 35（11）：10849-10854.
[25] Jiang R，Cai XY，Yang ZH，et al. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma [J]. Chin J Cancer，2015，34（6）：237-246.
[26] Li XH，Chang H，Xu BQ，et al. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma： an analysis of a prospective study [J]. Cancer Med，2017，6（1）：310-319.
[27] Yang S，Zhao K，Ding X，et al. Prognostic Significance of Hematological Markers for Patients with Nasopharyngeal Carcinoma： A Meta-analysis [J]. J Cancer，2019，10（11）：2568-2577.
[28] Jiang W，Chen Y，Huang J，et al. Systemic immune-inflammation index predicts the clinical outcome in patients with nasopharyngeal carcinoma： a propensity score-matched analysis [J]. Oncotarget，2017，8（39）：66075-66086.
[29] Oei R，Ye L，Kong F，et al. Prognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma： a propensity score matching study [J]. Cancer Manag Res，2018，10：2785-2797.
[30] Zeng X，Liu G，Pan Y，et al. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma [J]. J Cell Mol Med，2020，24（15）：8326-8349.
[31] Feng Y，Zhang N，Wang S，et al. Systemic Inflammation Response Index Is a Predictor of Poor Survival in Locally Advanced Nasopharyngeal Carcinoma： A Propensity Score Matching Study [J]. Front Oncol，2020，10：575417.
[32] Chen Y，Jiang W，Xi D，et al. Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas [J]. J Investig Med，2019，67（3）：691-698.
[33] Valero C，Pardo L，Sansa A，et al. Prognostic capacity of Systemic Inflammation Response Index （SIRI） in patients with head and neck squamous cell carcinoma [J]. Head Neck，2020，42（2）：336-343.
[34] Buzby GP，Mullen JL，Matthews DC，et al. Prognostic nutritional index in gastrointestinal surgery [J]. Am J Surg，1980，139（1）：160-167.
[35] Du XJ，Tang LL，Mao YP，et al. Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinoma [J]. J Transl Med，2015，13：364.
[36] Wei GB，Lu YY，Liao RW，et al. Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma [J]. Onco Targets Ther，2016，9：5955-5961.
[37] Miao J，Xiao W，Wang L，et al. The value of the Prognostic Nutritional Index （PNI） in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma （NPC） patients receiving intensity-modulated radiotherapy （IMRT） with or without chemotherapy [J]. J Cancer Res Clin Oncol，2017，143（7）：1263-1273.
[38] McMillan DC. Systemic inflammation，nutritional status and survival in patients with cancer [J]. Curr Opin Clin Nutr Metab Care，2009，12（3）：223-226.
[39] Chen C，Sun P，Dai QS，et al. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma [J]. PLoS One，2014，9（11）：e112581.
[40] Zhang Y，Zhou GQ，Liu X，et al. Exploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma [J]. J Cancer，2016，7（11）：1406-1412.
[41] Wang Y，Yang L，Xia L，et al. High C-reactive protein/albumin ratio predicts unfavorable distant metastasis-free survival in nasopharyngeal carcinoma： a propensity score-matched analysis [J]. Cancer Manag Res，2018， 10：371-381.
[42] Sun P，Chen C，Xia Y，et al. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma [J]. Dis Markers，2017，2017：6570808. |
|
|
|
